Levitan Idan, Fichman Suzana, Laviv Yosef
Departments of Neurosurgery, Rabin Medical Center, Petha Tiqva, Israel.
Departments of Pathology, Rabin Medical Center, Petha Tiqva, Israel.
Surg Neurol Int. 2020 Jul 18;11:195. doi: 10.25259/SNI_171_2020. eCollection 2020.
Malignant atypical teratoid rhabdoid tumor (ATRT) usually develops in children. ATRTs are rare in adults, with only one case in the literature describing involvement of the anterior skull base. These primary intracranial tumors are characterized molecularly as SMARCB1 (INI1) deficient. Different types of such SMARCB1-deficient tumors exist in adulthood, usually in the form of extracranial tumors. Very few cases of such a new entity, named SMARCB1-deficient sinonasal carcinoma have been described with intracranial penetration and involvement of the anterior cranial fossa.
A 36-year-old male presented with acute cognitive deterioration. Over few hours, he developed a fulminant herniation syndrome. Imaging showed a tumor in the anterior cranial fossa surrounded by massive brain edema. The tumor has destroyed the frontal bone with involvement of the nasal cavities and paranasal sinuses. The patient underwent emergent decompressive craniectomy and tumor debulking but could not be saved. Pathological analysis revealed a highly cellular tumor without rhabdoid cells but with areas of necrosis. Further immunohistochemical stains revealed that neoplastic cells were diffusely and strongly positive for epithelial membrane antigen and P63 and negative for SMARCB1 (i.e., loss of expression), confirming the diagnosis of sinonasal carcinoma.
To the best of our knowledge, this is the first report of a fulminant presentation of a SMARCB1- deficient tumor in young adult, involving the anterior cranial fossa and the paranasal sinuses. The main differential diagnosis of aggressive, primary, intracranial SMARCB1-deficient tumors in adults includes ATRT, SMARCB1- deficient sinonasal carcinoma, rhabdoid meningioma, and rhabdoid glioblastoma. Atypical tumors involving the anterior skull base without a clear histopathological pattern should therefore be checked for SMARCB1 expression.
恶性非典型畸胎样横纹肌样瘤(ATRT)通常发生于儿童。成人ATRT罕见,文献中仅有1例描述了前颅底受累情况。这些原发性颅内肿瘤在分子水平上的特征是SMARCB1(INI1)缺陷。成年期存在不同类型的此类SMARCB1缺陷肿瘤,通常为颅外肿瘤形式。很少有关于这种新实体,即SMARCB1缺陷型鼻窦癌伴颅内侵犯和前颅窝受累的病例报道。
一名36岁男性出现急性认知功能恶化。在数小时内,他发展为暴发性脑疝综合征。影像学检查显示前颅窝有一个肿瘤,周围伴有大量脑水肿。肿瘤已破坏额骨,累及鼻腔和鼻窦。患者接受了紧急减压颅骨切除术和肿瘤减瘤手术,但未能挽救生命。病理分析显示肿瘤细胞丰富,无横纹肌样细胞,但有坏死区域。进一步的免疫组化染色显示肿瘤细胞上皮膜抗原和P63弥漫性强阳性,SMARCB1阴性(即表达缺失),确诊为鼻窦癌。
据我们所知,这是首例关于年轻成人中SMARCB1缺陷肿瘤暴发性表现累及前颅窝和鼻窦的报道。成人侵袭性原发性颅内SMARCB1缺陷肿瘤的主要鉴别诊断包括ATRT、SMARCB1缺陷型鼻窦癌、横纹肌样脑膜瘤和横纹肌样胶质母细胞瘤。因此,对于累及前颅底且组织病理学模式不明确的非典型肿瘤,应检查SMARCB1表达情况。